Taylor, A orcid.org/0000-0003-2295-2611 and Rudd, CE (2019) Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer Therapy. Journal of Immunological Sciences, 3 (1). pp. 9-12. ISSN 2578-3009
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | ©2019 Taylor A. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.(http://creativecommons.org/licenses/by/4.0/). |
Keywords: | Nivolumab; Pembrolizumab |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Infection and Immunity (Leeds) |
Funding Information: | Funder Grant number Cancer Research UK C11071/A20105 |
Depositing User: | Symplectic Publications |
Date Deposited: | 01 Jul 2019 09:58 |
Last Modified: | 01 Jul 2019 09:59 |
Status: | Published |
Publisher: | Journal of Immunological Sciences |
Identification Number: | 10.29245/2578-3009/2019/1.1167 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:147975 |